Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.00
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.50 (10.00%)
Open: 5.25
High: 5.25
Low: 5.00
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - The Allergy Therapeutics Plc

20 Jun 2023 09:57

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

River and Mercantile Asset Management PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

The Allergy Therapeutics PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19/06/2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

0.1P ORDINARY

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

25,700,000

3.7844%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

25,700,000

3.7844%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

0.1p Ordinary

Sell

3,000,000

0.014092

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

20 June 2023

Contact name:

Operational Compliance Department

River and Mercantile

Raela Tomas

Telephone number*:

+44 20 3327 5653

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230620035004/en/

Copyright Business Wire 2023

Date   Source Headline
13th Nov 20084:54 pmRNSHolding(s) in Company
28th Oct 200810:19 amRNSAnnual Report and Accounts
29th Sep 200810:46 amRNSHolding(s) in Company
22nd Sep 20087:00 amRNSFinal Results
22nd Sep 20087:00 amRNSResearch Update
22nd Aug 20083:06 pmRNSHolding(s) in Company
9th Jun 20087:00 amRNSResearch Update
14th May 20087:00 amRNSResearch Update
7th May 200811:50 amRNSDirector/PDMR Shareholding
15th Apr 20082:28 pmRNSAIM Notice 26
17th Mar 20087:01 amRNSInterim Results
14th Mar 200811:59 amRNSHolding(s) in Company
7th Mar 20081:47 pmRNSHolding(s) in Company
31st Jan 20087:00 amRNSNotice of Results
29th Jan 20084:15 pmRNSHolding(s) in Company - Amend
29th Jan 200812:42 pmRNSHolding(s) in Company
14th Jan 20087:01 amRNSChange of Adviser
27th Dec 200710:21 amRNSGrant of Options
12th Dec 200710:28 amRNSAvailability of Annual Report
29th Nov 20072:22 pmRNSResult of AGM
16th Nov 20073:31 pmRNSDirector/PDMR Shareholding
9th Nov 20073:24 pmRNSHolding(s) in Company
1st Nov 20077:02 amRNSResearch Update
29th Oct 20073:39 pmRNSHolding(s) in Company
26th Oct 20073:10 pmRNSDirector/PDMR Shareholding
11th Oct 200710:33 amRNSHolding(s) in Company
25th Sep 20077:00 amRNSFinal Results
14th Aug 20078:00 amRNSChange of Adviser
10th Aug 20079:28 amRNSAIM Rule 26
6th Aug 200711:03 amRNSHolding(s) in Company
24th Jul 200710:41 amRNSResearch Update
17th Jul 20073:36 pmRNSHolding(s) in Company
11th Jul 200710:01 amRNSClinical Update
19th Jun 200711:03 amRNSHolding(s) in Company
14th Jun 20077:01 amRNSResearch Update
8th Jun 20076:00 pmRNSAppointment of Joint Broker
29th May 20079:15 amRNSEur40 million Debt Facility
29th May 20077:02 amRNSEUR40 million Debt Facility
8th May 200710:45 amRNSHolding(s) in Company
18th Apr 20077:01 amRNSResearch Update
2nd Apr 20077:02 amRNSResearch Update
23rd Mar 200711:42 amRNSHolding(s) in Company
23rd Mar 20077:01 amRNSRe Investment
5th Mar 200712:04 pmRNSHolding(s) in Company
28th Feb 20077:01 amRNSInterim Results
27th Feb 200710:21 amRNSHolding(s) in Company
15th Feb 20072:29 pmRNSHolding(s) in Company
6th Feb 20074:46 pmRNSHolding(s) in Company
5th Feb 20073:04 pmRNSHolding(s) in Company
31st Jan 200710:18 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.